METHODS AND COMPOSITIONS COMPRISING AN ANTI-IL13 ANTIBODY AND RESIDUAL HAMSTER PHOSPHOLIPASE B-LIKE 2

Purified recombinant polypeptides isolated from Chinese hamster ovary host cells, including compositions comprising anti-IL13 antibodies and residual hamster phospholipase B-like 2 (PLBL2), such as therapeutic antibodies, and methods of making and using such polypeptides are provided. L'inventi...

Full description

Saved in:
Bibliographic Details
Main Authors LOWE, JOHN, VANDERLAAN, MARTIN, YU, X. CHRISTOPHER, KADKHODAYAN FISCHER, SALOUMEH, AMURAO, ANNAMARIE, NAIM, ATIA, FRANKLIN, JAYME, SANCHEZ, AILEN M, TESKE, CHRISTOPHER A, FISHER, SUSAN C, VICTA, CORAZON
Format Patent
LanguageEnglish
French
Published 21.03.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Purified recombinant polypeptides isolated from Chinese hamster ovary host cells, including compositions comprising anti-IL13 antibodies and residual hamster phospholipase B-like 2 (PLBL2), such as therapeutic antibodies, and methods of making and using such polypeptides are provided. L'invention concerne des polypeptides recombinants purifiés isolés de cellules ovariennes hôtes de hamster comprenant des anticorps, tels que des anticorps thérapeutiques, et des procédés de production et d'utilisation de ces polypeptides.
Bibliography:Application Number: CA20142921999